Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patients - Concepedia

Concepedia

Publication | Open Access

Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patients

DOI Full Paper Access

298

Citations

28

References

2004

Year

Tania Crombet, Marta Osorio, Teresa Cruz, Carlos Gómez Roca, Ramón del Castillo, Rosa Mon, Normando Iznaga-Escobar, René Figueredo, James Koropatnick, Enrique Renginfo,

Journal of Clinical Oncology

Abstract

h-R3 is a well-tolerated drug that may enhance radiocurability of unresectable head and neck neoplasms.

References

	Year	Citations

Page 1